secwatch.observer — SEC 8-K summary
======================================

Issuer:     AGILENT TECHNOLOGIES, INC. (A)
CIK:        0001090872
Form:       8-K
Filed at:   2024-12-13T23:59:59+00:00
Accession:  0001090872-24-000045
Event type: other_material
Sentiment:  neutral
Materiality: 0.55
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Agilent reorganizes into three reportable segments: LSD, Applied, CrossLab
--------------------------------------------------------------------------

- New segments: Life Sciences & Diagnostics Markets, Applied Markets, Agilent CrossLab, effective FY2025.
- FY24 segment revenue: LSD $2,466M, CrossLab $2,747M, Applied $1,297M; operating margins 19.6%, 33.7%, 24.0%.
- FY23 segment revenue: LSD $2,780M, CrossLab $2,656M, Applied $1,397M; LSD operating margin dropped from 24.2% to 19.6%.
- Historical unaudited segment data provided for FY22, FY23, FY24; prior periods will be recast going forward.
- No change to previously reported consolidated results; reorganization is market-focused, customer-centric.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1090872/000109087224000045/0001090872-24-000045-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1090872/000109087224000045/a-20241213.htm
  HTML page:      https://secwatch.observer/filing/0001090872-24-000045

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer